Pharmaceutical Industry Information Portal

HomeNewsletter

Newsletter

St. Petersburg-based research institute files application for registering its COVID-19 vaccine – State Register

The St. Petersburg Research Institute of Vaccines and Sera of the Russian Federal Medical-Biological Agency (FMBA) has filed an application with the Health Ministry...

Russian drug Longidaza® to help cope with post-Covid is patented in India

Longidaza®, developed in Russia, received a patent in India. This was reported by the company "Petrovax". Thus, Longidasa, which already has patents in a...

Brightway Group pharmaceutical plant will be opened in CEZ Technopolis Moscow

The resident of SEZ Technopolis Moscow plans to complete the construction of a new large pharmaceutical production at Alabushevo site this year. The enterprise...

Spallanzani Institute in Italy: Sputnik V shows higher Omicron-antibody levels than Pfizer in preliminary study

The Gamaleya National Research Center of Epidemiology and Microbiology (Gamaleya Center) and the Russian Direct Investment Fund (RDIF, Russia’s sovereign wealth fund, investor in...

The new direct acting anticoagulant in the anticovid portfolio of Promomed Group

Promomed Group received marketing authorization certificate for a medicinal product with nadroparin calcium as active ingredient. Nadroparin is a low molecular weight heparin. It...

Unvaccinated Djokovic bets on a COVID-19 cure

The Serbian superstar, who became a focus of the global vaccine debate over his failed attempt to enter Australia without being inoculated, holds a...
spot_img

Expert Articles

spot_img